(Total Views: 851)
Posted On: 06/03/2019 5:10:43 PM
Post# of 158215
Lerolimab selectively blocks CCR5 while allowing other immune functions to continue. Which is why CD8 T-cells continue to increase with leronlimab and not with maraviroc.
I have to wonder what level of CD8 T-cell production occurs with CCR5 delta 32.
I have to wonder what level of CD8 T-cell production occurs with CCR5 delta 32.
(1)
(0)
